Journal of Clinical Lipidology

Scope & Guideline

Innovating lipid management for better patient outcomes.

Introduction

Welcome to the Journal of Clinical Lipidology information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Journal of Clinical Lipidology, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN1933-2874
PublisherELSEVIER SCIENCE INC
Support Open AccessNo
CountryNetherlands
TypeJournal
Converge1970, from 2007 to 2024
AbbreviationJ CLIN LIPIDOL / J. Clin. Lipidol.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressSTE 800, 230 PARK AVE, NEW YORK, NY 10169

Aims and Scopes

The Journal of Clinical Lipidology focuses on advancing the understanding of lipid metabolism, lipid disorders, and their implications for cardiovascular health. It encompasses a wide range of studies that examine genetic, clinical, and therapeutic aspects of lipidology, aiming to improve patient care through innovative research and clinical practice guidelines.
  1. Lipid Disorders and Genetic Factors:
    The journal emphasizes research on genetic predispositions to lipid disorders, particularly familial hypercholesterolemia, dyslipidemia, and related metabolic syndromes. This includes studies on genetic mutations, their phenotypic expressions, and implications for diagnostics and treatment.
  2. Clinical Management of Lipid Disorders:
    A significant focus is placed on the clinical management of patients with lipid disorders, including the effectiveness of various pharmacotherapies, dietary interventions, and lifestyle modifications aimed at reducing cardiovascular risk.
  3. Innovative Therapeutic Approaches:
    The journal highlights novel therapeutic strategies, such as PCSK9 inhibitors, antisense oligonucleotides, and other lipid-lowering agents, along with their clinical outcomes and safety profiles.
  4. Epidemiology and Public Health:
    Research addressing the epidemiology of lipid disorders, their prevalence in different populations, and the impact of public health initiatives on lipid management and cardiovascular disease prevention is a key area of interest.
  5. Implementation Science in Lipidology:
    The journal explores the application of implementation science to improve lipid screening, diagnosis, and management protocols within clinical settings, enhancing patient outcomes and healthcare delivery.
In recent years, the Journal of Clinical Lipidology has witnessed a substantial shift towards several emerging themes that reflect current trends in lipid research and clinical practice. These themes highlight the evolving understanding of lipidology and its implications for cardiovascular health.
  1. Familial Hypercholesterolemia and Genetic Testing:
    Research on familial hypercholesterolemia, including genetic testing and screening guidelines, has surged. This reflects a growing recognition of the importance of early diagnosis and management of genetically predisposed individuals to prevent cardiovascular events.
  2. Lipoprotein(a) and Cardiovascular Risk:
    There is an increasing focus on lipoprotein(a) as an independent risk factor for cardiovascular disease, with studies investigating its measurement, clinical implications, and management strategies, indicating a significant shift in understanding lipid-related risks.
  3. Implementation of Novel Therapies:
    The journal is trending towards studies evaluating the real-world effectiveness and safety of novel lipid-lowering therapies, particularly PCSK9 inhibitors and RNA-based treatments, as they become more integrated into clinical practice.
  4. Diversity and Disparities in Lipid Management:
    Emerging themes include the examination of disparities in access to lipid management therapies across different populations, including racial, ethnic, and socioeconomic factors that influence treatment outcomes.
  5. Lipidomics and Precision Medicine:
    Research integrating lipidomics into clinical practice is gaining traction, focusing on personalized approaches to lipid management based on individual lipid profiles and genetic backgrounds, reflecting a move towards precision medicine in lipidology.

Declining or Waning

While the Journal of Clinical Lipidology has a robust focus on various lipid-related themes, certain areas appear to be declining in prominence based on recent publications. This may reflect shifts in research priorities or emerging trends that overshadow previously popular topics.
  1. Traditional Dietary Approaches:
    There is a noticeable decline in studies focusing on traditional dietary approaches to managing dyslipidemia, such as low-fat diets, as newer research emphasizes the role of specific dietary components like omega-3 fatty acids and the Mediterranean diet.
  2. Basic Lipid Biochemistry Studies:
    Research centered solely on basic lipid biochemistry without clinical implications is becoming less prevalent. The journal is now favoring studies that translate biochemical findings into clinical practice or patient outcomes.
  3. Historical Case Studies:
    The frequency of historical case studies documenting rare lipid disorders is decreasing, possibly due to a shift towards more contemporary clinical trials and cohort studies that provide more relevant data for current practices.
  4. Single-Center Studies:
    There is a waning interest in single-center studies that do not incorporate broader epidemiological data. The journal is increasingly prioritizing multi-center or population-based studies that provide more comprehensive insights.
  5. Non-Pharmacological Interventions:
    Research focusing on non-pharmacological interventions alone, such as exercise or lifestyle changes without pharmacotherapy, appears to be less frequent, as there is a stronger emphasis on integrated approaches combining medication and lifestyle modifications.

Similar Journals

Lipids in Health and Disease

Advancing lipid science for a healthier tomorrow.
Publisher: BMCISSN: Frequency: 1 issue/year

Lipids in Health and Disease, published by BMC, stands as a leading open-access journal dedicated to advancing the understanding of lipid metabolism and its implications for health and disease. Since its inception in 2002, this journal has fostered accessibility to cutting-edge research, ensuring that knowledge in this vital field is disseminated widely to researchers, clinicians, and students worldwide. With a commendable Q1 ranking in multiple categories including Clinical Biochemistry and Endocrinology, Diabetes and Metabolism, it appeals to a diverse readership, positioning itself at the forefront of research in biochemistry and medicine. It boasts an impressive Scopus rank, where it excels in areas such as Endocrinology, Diabetes and Metabolism and Clinical Biochemistry, making it an essential resource for those looking to deepen their understanding of lipid biology and its clinical applications. Researchers can share and access findings that have significant implications for public health and disease prevention, emphasizing the journal's commitment to fostering innovation and collaboration in the scientific community.

Journal of Diabetology

Driving progress in diabetes research and treatment.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 2543-3288Frequency: 3 issues/year

The Journal of Diabetology, published by Wolters Kluwer Medknow Publications, is a premier platform dedicated to advancing the understanding and management of diabetes and related metabolic disorders. Since its inception in 2010, this Open Access journal has provided researchers and healthcare professionals with a wealth of knowledge through rigorous peer-reviewed articles that cover clinical research, epidemiology, and innovative treatment strategies. With an E-ISSN of 2078-7685 and a commitment to disseminating high-quality scientific work, the journal plays a pivotal role in contributing to the global discourse on diabetes care and prevention. Its dedication to accessibility enhances its impact on both established scholars and emerging researchers seeking to make meaningful contributions in the field. By fostering a collaborative environment, the Journal of Diabetology aims to bridge the gap between research and practical implementation, ultimately improving outcomes for individuals affected by diabetes.

PROSTAGLANDINS & OTHER LIPID MEDIATORS

Fostering Collaboration in Lipid Research
Publisher: ELSEVIER SCIENCE INCISSN: 1098-8823Frequency: 6 issues/year

PROSTAGLANDINS & OTHER LIPID MEDIATORS, published by Elsevier Science Inc, is a leading journal dedicated to the advancements in the field of lipid mediators, with a specific focus on prostaglandins and other bioactive lipids. This journal, indexed under ISSN 1098-8823 and E-ISSN 2212-196X, serves as a crucial platform for researchers and professionals to disseminate significant findings that span multiple disciplines, including Biochemistry, Cell Biology, Pharmacology, and Physiology. In the 2023 category quartiles, it has achieved commendable positions such as Q2 in Biochemistry and Q2 in Physiology, underscoring its importance and influence in these domains. Although it is not an open-access journal, it provides robust access options, enhancing the visibility of vital research. With its establishment in 1996, the journal continues its commitment to fostering innovative research until 2024, making it an essential resource for those involved in the dynamic realms of lipid biology and medical research.

Current Vascular Pharmacology

Innovating Drug Development for Cardiovascular Care
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1570-1611Frequency: 6 issues/year

Current Vascular Pharmacology is a premier academic journal published by Bentham Science Publications Ltd, focusing on the intersection of pharmacology and cardiovascular medicine. With an impact factor that reflects its significance in the field, this journal ranks in the Q1 category for both Pharmacology and Cardiology, showcasing its dedication to high-quality research. Its Scopus ranks place it in the top percentile of its categories, highlighting its influence among scholars and practitioners alike. Issued since 2003 and continuing through 2024, Current Vascular Pharmacology aims to disseminate cutting-edge findings and foster knowledge exchange among researchers, professionals, and students engaged in cardiovascular pharmacology. Despite being a subscription-based journal, it remains a vital resource for those seeking the latest advancements in drug development and therapeutic interventions for vascular diseases. Located in the United Arab Emirates, the journal serves as an essential platform for global discourse on vascular health.

Journal of the ASEAN Federation of Endocrine Societies

Pioneering Discoveries: Elevating Endocrine Science in ASEAN
Publisher: ASEAN FEDERATION ENDOCRINE SOCISSN: 0857-1074Frequency: 2 issues/year

Welcome to the Journal of the ASEAN Federation of Endocrine Societies, a pioneering publication dedicated to advancing knowledge and research in the fields of Endocrinology, Diabetes, and Metabolism. Established by the ASEAN Federation Endocrine Society and open access since 2011, this journal enhances the dissemination of critical findings and encourages collaboration among professionals and researchers across Southeast Asia and beyond. With an ISSN of 0857-1074 and E-ISSN of 2308-118X, the journal is indexed within Quartile 4 in the 2023 rankings of its categories, reflecting its commitment to providing a platform for scholarly work despite its emerging status. Situated in the Philippines, the journal focuses on the latest trends, treatments, and innovative research approaches in endocrinology, making it an essential resource for academics, clinicians, and students alike. We invite you to explore our content and contribute to advancing the endocrine sciences.

Clinical Nutrition ESPEN

Empowering Practitioners with Cutting-Edge Nutritional Insights
Publisher: ELSEVIERISSN: 2405-4577Frequency: 6 issues/year

Clinical Nutrition ESPEN is a distinguished journal published by ELSEVIER, focusing on the critical intersection of clinical nutrition and metabolic health. With an ISSN of 2405-4577, this journal serves as an essential resource for researchers, practitioners, and students in the fields of Endocrinology, Diabetes and Metabolism as well as Nutrition and Dietetics. Operating out of the United Kingdom, it has garnered a respectable Q2 ranking in both categories for 2023, indicating its significant impact and relevance in the field. Although it does not follow an open access model, the journal offers valuable insights into contemporary nutrition research, clinical practices, and dietary interventions, making it a vital tool for those committed to improving patient outcomes through nutritional science. In its evolving journey, covering work from 2015 to 2024, Clinical Nutrition ESPEN continues to shape the dialogue in nutrition research, addressing pressing health challenges and fostering innovation in dietetic practice.

Current Atherosclerosis Reports

Elevating the standard of cardiovascular scholarship.
Publisher: CURRENT MEDICINE GROUPISSN: 1523-3804Frequency: 12 issues/year

Current Atherosclerosis Reports, published by CURRENT MEDICINE GROUP, is a leading scientific journal in the field of Cardiology and Cardiovascular Medicine, boasting an impressive Q1 ranking in its category as of 2023. This esteemed journal, with an ISSN of 1523-3804 and an E-ISSN of 1534-6242, has been a cornerstone of cardiovascular research since its inception in 1999, continuing to publish cutting-edge studies through 2024. With unparalleled insights into the mechanisms, prevention, and treatment of atherosclerosis, it serves as an essential resource for researchers, healthcare professionals, and students alike. Although not an open-access journal, it is highly regarded within the academic community, highlighted by its Scopus rank of #54 out of 387 in its field, placing it in the 86th percentile. The journal's commitment to advancing knowledge in cardiovascular health underscores its integral role in guiding clinical practices and influencing future research directions.

CHEMISTRY AND PHYSICS OF LIPIDS

Fostering groundbreaking research in lipid-related fields.
Publisher: ELSEVIER IRELAND LTDISSN: 0009-3084Frequency: 8 issues/year

Chemistry and Physics of Lipids is a prestigious and influential journal dedicated to advancing the understanding of lipid chemistry and biophysics. Published by Elsevier Ireland Ltd, it serves as a vital resource for researchers and professionals in the fields of biochemistry, cell biology, and molecular biology. The journal has a strong standing within the academic community, as reflected in its 2023 Scopus rankings, where it places in the 82nd percentile for organic chemistry and maintains significant positions in various biochemistry subfields. Spanning from 1966 to 2024, it fosters a comprehensive discourse on lipid-related research and innovation. As a renowned publication in the Q2 and Q3 quartiles across several categories, it supports the dissemination of high-quality research aimed at elucidating lipid functions and their implications in health and disease. Researchers and students alike will find this journal invaluable for staying updated with the latest developments and trends in lipid research.

Cardiovascular Endocrinology & Metabolism

Innovating Research at the Intersection of Cardiology and Endocrinology
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 2574-0954Frequency: 4 issues/year

Cardiovascular Endocrinology & Metabolism is a leading open-access journal dedicated to advancing our understanding of the interconnections between cardiovascular health and endocrine functions. Published by Lippincott Williams & Wilkins, this journal serves as a vital resource for researchers and clinicians alike, providing timely insights into the intricate relationships between metabolic disorders and cardiovascular diseases. With an impressive impact factor and categorized in Q2 for both Cardiology and Cardiovascular Medicine as well as Endocrinology, Diabetes, and Metabolism, it holds a significant position within its respective fields. The journal has been fully open access since its inception in 2012, ensuring that critical research is accessible to a global audience. By fostering innovation and collaboration, Cardiovascular Endocrinology & Metabolism aims to promote better health outcomes and stimulate novel research directions, making it an essential resource for professionals striving to bridge the gaps between these two critical domains.

LIPIDS

Unraveling lipid mysteries since 1966.
Publisher: WILEYISSN: 0024-4201Frequency: 6 issues/year

LIPIDS is a renowned peer-reviewed journal published by Wiley, dedicated to the field of lipid research, encompassing biochemistry, molecular biology, and organic chemistry. With its roots dating back to 1966 and a commitment to advancing knowledge until 2024, this journal serves as a vital platform for sharing significant findings in lipid biochemistry and its applications in health and disease. Although it currently does not offer Open Access options, it maintains a respectable standing with a Q3 ranking in Biochemistry and Organic Chemistry, and a Q4 ranking in Cell Biology based on the 2023 category quartiles. Additionally, its Scopus rankings reflect a solid position within the organic chemistry and biochemistry subfields. Published from Germany, LIPIDS caters to researchers, professionals, and students eager to explore the roles of lipids in biological processes and innovatory applications in various scientific disciplines.